Associated Papers
CRISPR for cystic fibrosis: Advances and insights from a systematic review.
Nicosia L et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy, 2025
Alternative splicing and residual function potentially expand the therapeutic landscape of the CFTRdele2ins182 variant.
Pastorino C et al.
Plos One, 2025
Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells.
Bulcaen M et al.
Cell Reports. Medicine, 2024
Diversity of CFTR variants across ancestries characterized using 454,727 UK biobank whole exome sequences.
Ideozu JE et al.
Genome Medicine, 2024
38515211 (PubMed )
Supplement: 13073_2024_1316_MOESM1_ESM.xlsx › Table_S1A
Identification of Allosteric Inhibitors against Active Caspase-6.
Tubeleviciute-Aydin A et al.
Scientific Reports, 2019
Select a paper to view details